Navigation Links
Columbia leads national effort to develop early intervention for schizophrenia
Date:7/21/2009

NEW YORK (July 21, 2009) Columbia University Medical Center's Jeffrey A. Lieberman, M.D., a renowned expert in the field of schizophrenia, has been selected by the National Institute of Mental Health (NIMH) of the National Institutes of Health as principal investigator of a nationwide effort to develop an optimal early intervention strategy for treating people experiencing a first episode of the psychotic symptoms of schizophrenia.

Research has shown that early treatment can alter the course of schizophrenia and related psychotic disorders by dramatically slowing progression; reducing disability, mortality, and the expense of care; and increasing recovery. The Recovery After Initial Schizophrenic Episode (RAISE) study, funded at $9.9 million for two years, has the potential to be extended to six years and a total of $21.3 million if certain milestones are met.

"This award will enable researchers to demonstrate how a strategically timed intervention at the onset of symptoms can prevent the debilitating effects of one of humankind's most devastating and costly mental disorders," says Dr. Lieberman, the Lawrence E. Kolb Professor and chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; director, New York State Psychiatric Institute; and director, Lieber Center for Schizophrenia Research. "This is a unique and historic opportunity to bring, more rapidly than we could have imagined, research and clinical efforts to bear on the question of how to reduce the burden to patient, family and society of this devastating disease."

Dr. Lieberman will lead a team of researchers from Columbia University Medical Center, the University of Maryland; University of North Carolina, UCLA, Dartmouth College and Harvard University.

Lisa B. Dixon, M.D., MPH, professor of psychiatry, University of Maryland School of Medicine; associate director of research for the Mental Illness Research, Education and Clinica
'/>"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
2. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
3. HHS Secretary Leavitt to Address Columbia School of International and Public Affairs
4. Columbiana County Board of MR/DD Chooses Q Continuum(TM) System
5. University of British Columbia Research Shows Health Benefits of GameBike (TM)
6. Columbia Center for Childrens Environmental Health receives NIEHS grant to study asthma
7. Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes
8. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
9. Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk)
10. Format-Studio Selected by Columbia University Mailman School of Public Health
11. NYP/Columbia physician-scientists present at ASCO 44th annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... HIV/AIDS in South Africa may provide insight on how to ... areas of the world, which may have limited access to ... , A report on the global AIDS epidemic published ... pandemic, which has left 12 million children orphaned in Sub-Saharan ...
(Date:4/14/2014)... marvels of the 20th century, is currently losing a ... But scientists at the University of South Carolina have ... effectiveness, even against so-called "superbugs." , Bacteria have been ... of drugs since their first wide-scale use as antibiotics ...
(Date:4/14/2014)... ,, West Orange, NJ. April 10, 2014. John DeLuca, ... grant from Biogen Idec to study how persons with ... entitled "The Use of Actual Reality to Measure Everyday ... to conduct this research. Dr. DeLuca is senior VP ...
(Date:4/14/2014)... that the molecule, called microRNA 135b, is a vital ... the growth of bowel cancers. , Drugs targeted at ... cancer-causing mutations at once, while tests for it could ... believe. , The research was carried out by an ...
(Date:4/14/2014)... -- with symptoms increasing dramatically during some of the most ... study has found. , Depressive symptoms increased on average by ... these young men, who were around 25 years old when ... as their children. The results of the study were published ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:'MicroRNA' could be key target for bowel cancer treatment 2Health News:Young dads at high risk of depression, too 2
... with network providers, WOODLAND HILLS, Calif., April ... had the highest workplace,absenteeism at 2,761,000 lost work ... to cost employers $522 million annually. Anthem Blue ... to help identify and resolve issues that they ...
... from Innovative Program, SEATTLE, April 16 ... partnering with Technogym USA to bring the finest,fitness ... Technogym,The Wellness Company is the official fitness equipment ... of retirement living,communities are comparable to five-star hotels. ...
... should lead to more effective vaccines, researchers say , , WEDNESDAY, ... virus that produce seasonal flu epidemics start in East Asia ... world, researchers report. , And by focusing on new flu ... their forecast of seasonal flu strains and develop better vaccines, ...
... to extend the reach of their High ... Dropout Prevention ,Boost, Campaign, NEW YORK, April 16 The ... Call program as part of their "Boost",national public service advertising campaign ... of Amare Stoudemire, NBA,All-Star and Captain of the Phoenix Suns, the ...
... Hit Especially Hard, According to New NCPA,Study, DALLAS, ... the greatest penalties on low-income workers when they work,extra ... today by the,National Center for Policy Analysis., "The ... said NCPA Senior Fellow Laurence Kotlikoff, Boston University,professor and ...
... - Higher blood levels of an immune system protein ... disease, researchers at The University of Texas M. D. ... of the American Association for Cancer Research. , Their ... marker of poor prognosis also points to a molecular ...
Cached Medicine News:Health News:Anthem Blue Cross Employee Assistance Program to Help Reduce Employee Absenteeism 2Health News:AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its' Communities 2Health News:AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its' Communities 3Health News:Seasonal Flu Outbreaks Start in Asia: Study 2Health News:Seasonal Flu Outbreaks Start in Asia: Study 3Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 2Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 3Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 4Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 5Health News:Tax Rates Mean Extra Work Doesn't Pay 2Health News:Interleukin-12 indicates survival prospects for melanoma patients 2
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... 30, 2012  Today, in conjunction with its Investor Day being ... PRXL ) announced forward-looking earnings expectations for the ... for Fiscal Year 2012, and for Fiscal Year 2013.  ... quarter of Fiscal Year 2012 and for all of Fiscal ...
...  Stiefel, a GSK (NYSE: GSK ) company, ... agreement for the acquisition by Stiefel of exclusive development ... in all territories outside of China, Taiwan, Macao and ... development for the treatment of psoriasis and atopic dermatitis. ...
Cached Medicine Technology:PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 2PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 3PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 4Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: